UNSPSC 85255807: Diagnosis of benign neoplasm on the carotid body

This classification denotes the group of activities that yields a diagnosis of Benign neoplasm on the Carotid body. Benign neoplasm on the Carotid body is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D35.5

UNSPSC 85255807 Diagnosis of benign neoplasm on the carotid body is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's abstract focus on a specific diagnostic pathology does not align with the recent opportunities posted under it, which instead solicit for enterprise diagnostic imaging systems, special education contracted services, and temporary health professional staffing across multiple clinical specialties. The opportunities reflect broad ancillary and clinical support services rather than diagnosis of a discrete neoplastic condition. This pattern suggests the code may be misapplied in state and local procurement databases or that the code's use has drifted substantially from its definition.

Recent activity under this code includes San Mateo Medical Center (SMMC), a California county public health system, requesting an RFP for a Diagnostic Imaging PACS (Picture Archiving and Communication System) with proposals due October 21, 2026; Birdville Independent School District in Texas soliciting sealed proposals for special education contracted services across 23 line items including speech pathology, occupational therapy, and behavioral analysis, also due October 21, 2026; and the County of Santa Clara Health System in California establishing a qualified vendor pool for temporary health professional staffing across ancillary clinical categories with the deadline of October 7, 2026. The issuing bodies span county public health systems, school districts, and health authority agencies. The geographic concentration is in California (San Mateo and Santa Clara counties) with activity in Texas, though the code's misalignment with its nominal diagnostic scope limits the relevance of recent opportunities to firms pursuing benign neoplasm diagnosis work specifically. Without additional opportunities that align with the code's stated purpose, procurement activity under this code does not indicate viable pursuit lanes for specialists in carotid body pathology diagnosis.